LABS.TO
Medipharm Labs Corp
Price:  
0.07 
CAD
Volume:  
35,300.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LABS.TO WACC - Weighted Average Cost of Capital

The WACC of Medipharm Labs Corp (LABS.TO) is 9.3%.

The Cost of Equity of Medipharm Labs Corp (LABS.TO) is 9.10%.
The Cost of Debt of Medipharm Labs Corp (LABS.TO) is 11.65%.

Range Selected
Cost of equity 8.00% - 10.20% 9.10%
Tax rate 1.30% - 4.00% 2.65%
Cost of debt 7.00% - 16.30% 11.65%
WACC 7.9% - 10.6% 9.3%
WACC

LABS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.95 0.99
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.00% 10.20%
Tax rate 1.30% 4.00%
Debt/Equity ratio 0.08 0.08
Cost of debt 7.00% 16.30%
After-tax WACC 7.9% 10.6%
Selected WACC 9.3%